Sarah Graham is an Analyst at Catalio Capital Management, LP. She focuses on private investments in life sciences and AI-enabled biomedical technologies.
Prior to joining Catalio, Sarah was a Senior Fellow at Johns Hopkins Technology Ventures, where she conducted due diligence on emerging technologies with commercial potential and supported startups spun out of Johns Hopkins.
Sarah is currently completing her Ph.D. in Cellular and Molecular Medicine at the Johns Hopkins University School of Medicine, where her research focuses on the early detection and prevention of pancreatic cancer through the integration of digital pathology, multi-omics, and machine learning. She holds a B.S. in Nutritional Sciences from the University of Arizona.